Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: Have we been missing anything?

13Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Current screening practices have been able to identify PMS2 mutations in 78 % of cases of colorectal cancer from the Colorectal Cancer Family Registry (Colon CFR) which showed solitary loss of the PMS2 protein. However the detection of large-scale deletions in the 3′ end of the PMS2 gene has not been possible due to technical difficulties associated with pseudogene sequences. Here, we utilised a recently described MLPA/long-range PCR-based approach to screen the remaining 22 % (n = 16) of CRC-affected probands for mutations in the 3′ end of the PMS2 gene. No deletions encompassing any or all of exons 12 through 15 were identified; therefore, our results suggest that 3′ deletions in PMS2 are not a frequent occurrence in such families. © 2013 Springer Science+Business Media Dordrecht.

Cite

CITATION STYLE

APA

Clendenning, M., Walsh, M. D., Gelpi, J. B., Thibodeau, S. N., Lindor, N., Potter, J. D., … Buchanan, D. D. (2013). Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: Have we been missing anything? Familial Cancer, 12(3), 563–566. https://doi.org/10.1007/s10689-012-9597-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free